Optimizing dermatological formulations of retinoic acid
β Scribed by David A. Schlichting; William M. Wooding; Michael Brown
- Publisher
- John Wiley and Sons
- Year
- 1973
- Tongue
- English
- Weight
- 471 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetics of three 13-cis-retinoic acid formulations were studied after intraperitoneal (ip) administration to rats. Rats were given ip injections of 2.5 mg of 13-cis-retinoic acid per 360 g of body weight; the drug was administered as an alkaline solution, suspended in corn oil, or as a
A method employing trifluoroacetic acid for the quantitative determination ofallrrans-retinoic acid and 13-cis-retinoic acid in serum is described. The method permits the detection of as little as 0.3 Kg of either compound. Retinoic acid can serve the general tissue functions of vitamin A, except i
## Abstract The aim of the present study was to optimize the process of drug release. Factors which influence drug release were studied in detail and their effects were described numerically. The factors studied were as follows: the concentration of the pharmacon (salicylic acid); its particle size
Some authors recently hypothesized the existence of a new retinoic acid (RA) phase in addition to the two already known polymorphs. We investigated RA polymorphism and our results exclude the presence of new modifications and refine the properties of the known forms. By comparison of simulated and a